 | • レポートコード：MRC2-11QY11632 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は糖尿病性黄斑浮腫治療のグローバル市場について調査・分析したレポートです。種類別（レーザー光凝固療法、薬物療法、ベバシズマブ、ラニビズマブ、トリアムシノロン）市場規模、用途別（病院、眼科クリニック、研究所、委託研究機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別糖尿病性黄斑浮腫治療の競争状況、市場シェア ・世界の糖尿病性黄斑浮腫治療市場：種類別市場規模 2015年-2020年（レーザー光凝固療法、薬物療法、ベバシズマブ、ラニビズマブ、トリアムシノロン） ・世界の糖尿病性黄斑浮腫治療市場：種類別市場規模予測 2021年-2026年（レーザー光凝固療法、薬物療法、ベバシズマブ、ラニビズマブ、トリアムシノロン） ・世界の糖尿病性黄斑浮腫治療市場：用途別市場規模 2015年-2020年（病院、眼科クリニック、研究所、委託研究機関） ・世界の糖尿病性黄斑浮腫治療市場：用途別市場規模予測 2021年-2026年（病院、眼科クリニック、研究所、委託研究機関） ・北米の糖尿病性黄斑浮腫治療市場分析：米国、カナダ ・ヨーロッパの糖尿病性黄斑浮腫治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの糖尿病性黄斑浮腫治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の糖尿病性黄斑浮腫治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの糖尿病性黄斑浮腫治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Genentech、Novartis、GlaxoSmithKline、Eyetech Pharmaceuticals、Alimera Sciences ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Diabetic macular edema (DME) is characterized by accumulation of fluid in the macula – a part of retina responsible for vision. Accumulation may cause by leakage of plasma constituents into the surrounding, consequently leading to edema.
Increasing prevalence of diabetes in the prime factor driving growth of global diabetic macular edema therapeutics market. The prevalence of diabetic macular edema is higher in type 2 diabetes patients than in type 1 diabetes patients. As per study conducted by University Hospital Sant Joan de Reus Spain, the incidence of diabetic macular edema is in the range of 0.9%-2.3%, annually, across the globe. Besides this, substantial R&D investment by pharmaceutical companies and advancement in ophthalmic surgrey techniques are some other factors fueling the growth of global diabetic macular edema treatment market.
Market Analysis and Insights: Global Diabetic Macular Edema Treatment Market
The global Diabetic Macular Edema Treatment market size is projected to reach US$ 3046.2 million by 2026, from US$ 3009.3 million in 2020, at a CAGR of 1.1%% during 2021-2026.
Global Diabetic Macular Edema Treatment Scope and Market Size
Diabetic Macular Edema Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diabetic Macular Edema Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Genentech
Novartis
GlaxoSmithKline
Eyetech Pharmaceuticals
Alimera Sciences
…
Market segment by Type, the product can be split into
Laser Photocoagulation Therapy
Pharmacological Therapy
Bevacizumab
Ranibizumab
Triamcinolone
Market segment by Application, split into
Hospitals
Ophthalmic Clinics
Research Institutes
Contract Research Organizations
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Diabetic Macular Edema Treatment Revenue
1.4 Market by Type
1.4.1 Global Diabetic Macular Edema Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Laser Photocoagulation Therapy
1.4.3 Pharmacological Therapy
1.4.4 Bevacizumab
1.4.5 Ranibizumab
1.4.6 Triamcinolone
1.5 Market by Application
1.5.1 Global Diabetic Macular Edema Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ophthalmic Clinics
1.5.4 Research Institutes
1.5.5 Contract Research Organizations
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Diabetic Macular Edema Treatment Market Perspective (2015-2026)
2.2 Global Diabetic Macular Edema Treatment Growth Trends by Regions
2.2.1 Diabetic Macular Edema Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Diabetic Macular Edema Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Diabetic Macular Edema Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Diabetic Macular Edema Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Diabetic Macular Edema Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Diabetic Macular Edema Treatment Players by Market Size
3.1.1 Global Top Diabetic Macular Edema Treatment Players by Revenue (2015-2020)
3.1.2 Global Diabetic Macular Edema Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Diabetic Macular Edema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Diabetic Macular Edema Treatment Market Concentration Ratio
3.2.1 Global Diabetic Macular Edema Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Diabetic Macular Edema Treatment Revenue in 2019
3.3 Diabetic Macular Edema Treatment Key Players Head office and Area Served
3.4 Key Players Diabetic Macular Edema Treatment Product Solution and Service
3.5 Date of Enter into Diabetic Macular Edema Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Diabetic Macular Edema Treatment Historic Market Size by Type (2015-2020)
4.2 Global Diabetic Macular Edema Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Diabetic Macular Edema Treatment Market Size by Application (2015-2020)
5.2 Global Diabetic Macular Edema Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Diabetic Macular Edema Treatment Market Size (2015-2020)
6.2 Diabetic Macular Edema Treatment Key Players in North America (2019-2020)
6.3 North America Diabetic Macular Edema Treatment Market Size by Type (2015-2020)
6.4 North America Diabetic Macular Edema Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Diabetic Macular Edema Treatment Market Size (2015-2020)
7.2 Diabetic Macular Edema Treatment Key Players in Europe (2019-2020)
7.3 Europe Diabetic Macular Edema Treatment Market Size by Type (2015-2020)
7.4 Europe Diabetic Macular Edema Treatment Market Size by Application (2015-2020)
8 China
8.1 China Diabetic Macular Edema Treatment Market Size (2015-2020)
8.2 Diabetic Macular Edema Treatment Key Players in China (2019-2020)
8.3 China Diabetic Macular Edema Treatment Market Size by Type (2015-2020)
8.4 China Diabetic Macular Edema Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Diabetic Macular Edema Treatment Market Size (2015-2020)
9.2 Diabetic Macular Edema Treatment Key Players in Japan (2019-2020)
9.3 Japan Diabetic Macular Edema Treatment Market Size by Type (2015-2020)
9.4 Japan Diabetic Macular Edema Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Diabetic Macular Edema Treatment Market Size (2015-2020)
10.2 Diabetic Macular Edema Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Diabetic Macular Edema Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Diabetic Macular Edema Treatment Market Size by Application (2015-2020)
11 India
11.1 India Diabetic Macular Edema Treatment Market Size (2015-2020)
11.2 Diabetic Macular Edema Treatment Key Players in India (2019-2020)
11.3 India Diabetic Macular Edema Treatment Market Size by Type (2015-2020)
11.4 India Diabetic Macular Edema Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Diabetic Macular Edema Treatment Market Size (2015-2020)
12.2 Diabetic Macular Edema Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Diabetic Macular Edema Treatment Market Size by Type (2015-2020)
12.4 Central & South America Diabetic Macular Edema Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Genentech
13.1.1 Genentech Company Details
13.1.2 Genentech Business Overview
13.1.3 Genentech Diabetic Macular Edema Treatment Introduction
13.1.4 Genentech Revenue in Diabetic Macular Edema Treatment Business (2015-2020))
13.1.5 Genentech Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Diabetic Macular Edema Treatment Introduction
13.2.4 Novartis Revenue in Diabetic Macular Edema Treatment Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Details
13.3.2 GlaxoSmithKline Business Overview
13.3.3 GlaxoSmithKline Diabetic Macular Edema Treatment Introduction
13.3.4 GlaxoSmithKline Revenue in Diabetic Macular Edema Treatment Business (2015-2020)
13.3.5 GlaxoSmithKline Recent Development
13.4 Eyetech Pharmaceuticals
13.4.1 Eyetech Pharmaceuticals Company Details
13.4.2 Eyetech Pharmaceuticals Business Overview
13.4.3 Eyetech Pharmaceuticals Diabetic Macular Edema Treatment Introduction
13.4.4 Eyetech Pharmaceuticals Revenue in Diabetic Macular Edema Treatment Business (2015-2020)
13.4.5 Eyetech Pharmaceuticals Recent Development
13.5 Alimera Sciences
13.5.1 Alimera Sciences Company Details
13.5.2 Alimera Sciences Business Overview
13.5.3 Alimera Sciences Diabetic Macular Edema Treatment Introduction
13.5.4 Alimera Sciences Revenue in Diabetic Macular Edema Treatment Business (2015-2020)
13.5.5 Alimera Sciences Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Diabetic Macular Edema Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Diabetic Macular Edema Treatment Revenue
Table 3. Ranking of Global Top Diabetic Macular Edema Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Diabetic Macular Edema Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Laser Photocoagulation Therapy
Table 6. Key Players of Pharmacological Therapy
Table 7. Key Players of Bevacizumab
Table 8. Key Players of Ranibizumab
Table 9. Key Players of Triamcinolone
Table 10. Global Diabetic Macular Edema Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Diabetic Macular Edema Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Diabetic Macular Edema Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Diabetic Macular Edema Treatment Market Share by Regions (2015-2020)
Table 14. Global Diabetic Macular Edema Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Diabetic Macular Edema Treatment Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Diabetic Macular Edema Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key Diabetic Macular Edema Treatment Players
Table 21. Global Diabetic Macular Edema Treatment Revenue by Players (2015-2020) (Million US$)
Table 22. Global Diabetic Macular Edema Treatment Market Share by Players (2015-2020)
Table 23. Global Top Diabetic Macular Edema Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Macular Edema Treatment as of 2019)
Table 24. Global Diabetic Macular Edema Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Diabetic Macular Edema Treatment Product Solution and Service
Table 27. Date of Enter into Diabetic Macular Edema Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Diabetic Macular Edema Treatment Market Size by Type (2015-2020) (Million US$)
Table 30. Global Diabetic Macular Edema Treatment Market Size Share by Type (2015-2020)
Table 31. Global Diabetic Macular Edema Treatment Revenue Market Share by Type (2021-2026)
Table 32. Global Diabetic Macular Edema Treatment Market Size Share by Application (2015-2020)
Table 33. Global Diabetic Macular Edema Treatment Market Size by Application (2015-2020) (Million US$)
Table 34. Global Diabetic Macular Edema Treatment Market Size Share by Application (2021-2026)
Table 35. North America Key Players Diabetic Macular Edema Treatment Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Diabetic Macular Edema Treatment Market Share (2019-2020)
Table 37. North America Diabetic Macular Edema Treatment Market Size by Type (2015-2020) (Million US$)
Table 38. North America Diabetic Macular Edema Treatment Market Share by Type (2015-2020)
Table 39. North America Diabetic Macular Edema Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. North America Diabetic Macular Edema Treatment Market Share by Application (2015-2020)
Table 41. Europe Key Players Diabetic Macular Edema Treatment Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Diabetic Macular Edema Treatment Market Share (2019-2020)
Table 43. Europe Diabetic Macular Edema Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Diabetic Macular Edema Treatment Market Share by Type (2015-2020)
Table 45. Europe Diabetic Macular Edema Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Diabetic Macular Edema Treatment Market Share by Application (2015-2020)
Table 47. China Key Players Diabetic Macular Edema Treatment Revenue (2019-2020) (Million US$)
Table 48. China Key Players Diabetic Macular Edema Treatment Market Share (2019-2020)
Table 49. China Diabetic Macular Edema Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. China Diabetic Macular Edema Treatment Market Share by Type (2015-2020)
Table 51. China Diabetic Macular Edema Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. China Diabetic Macular Edema Treatment Market Share by Application (2015-2020)
Table 53. Japan Key Players Diabetic Macular Edema Treatment Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Diabetic Macular Edema Treatment Market Share (2019-2020)
Table 55. Japan Diabetic Macular Edema Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Diabetic Macular Edema Treatment Market Share by Type (2015-2020)
Table 57. Japan Diabetic Macular Edema Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Diabetic Macular Edema Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Diabetic Macular Edema Treatment Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Diabetic Macular Edema Treatment Market Share (2019-2020)
Table 61. Southeast Asia Diabetic Macular Edema Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Diabetic Macular Edema Treatment Market Share by Type (2015-2020)
Table 63. Southeast Asia Diabetic Macular Edema Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Diabetic Macular Edema Treatment Market Share by Application (2015-2020)
Table 65. India Key Players Diabetic Macular Edema Treatment Revenue (2019-2020) (Million US$)
Table 66. India Key Players Diabetic Macular Edema Treatment Market Share (2019-2020)
Table 67. India Diabetic Macular Edema Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. India Diabetic Macular Edema Treatment Market Share by Type (2015-2020)
Table 69. India Diabetic Macular Edema Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. India Diabetic Macular Edema Treatment Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Diabetic Macular Edema Treatment Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Diabetic Macular Edema Treatment Market Share (2019-2020)
Table 73. Central & South America Diabetic Macular Edema Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Diabetic Macular Edema Treatment Market Share by Type (2015-2020)
Table 75. Central & South America Diabetic Macular Edema Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Diabetic Macular Edema Treatment Market Share by Application (2015-2020)
Table 77. Genentech Company Details
Table 78. Genentech Business Overview
Table 79. Genentech Product
Table 80. Genentech Revenue in Diabetic Macular Edema Treatment Business (2015-2020) (Million US$)
Table 81. Genentech Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Product
Table 85. Novartis Revenue in Diabetic Macular Edema Treatment Business (2015-2020) (Million US$)
Table 86. Novartis Recent Development
Table 87. GlaxoSmithKline Company Details
Table 88. GlaxoSmithKline Business Overview
Table 89. GlaxoSmithKline Product
Table 90. GlaxoSmithKline Revenue in Diabetic Macular Edema Treatment Business (2015-2020) (Million US$)
Table 91. GlaxoSmithKline Recent Development
Table 92. Eyetech Pharmaceuticals Company Details
Table 93. Eyetech Pharmaceuticals Business Overview
Table 94. Eyetech Pharmaceuticals Product
Table 95. Eyetech Pharmaceuticals Revenue in Diabetic Macular Edema Treatment Business (2015-2020) (Million US$)
Table 96. Eyetech Pharmaceuticals Recent Development
Table 97. Alimera Sciences Company Details
Table 98. Alimera Sciences Business Overview
Table 99. Alimera Sciences Product
Table 100. Alimera Sciences Revenue in Diabetic Macular Edema Treatment Business (2015-2020) (Million US$)
Table 101. Alimera Sciences Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetic Macular Edema Treatment Market Share by Type: 2020 VS 2026
Figure 2. Laser Photocoagulation Therapy Features
Figure 3. Pharmacological Therapy Features
Figure 4. Bevacizumab Features
Figure 5. Ranibizumab Features
Figure 6. Triamcinolone Features
Figure 7. Global Diabetic Macular Edema Treatment Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Ophthalmic Clinics Case Studies
Figure 10. Research Institutes Case Studies
Figure 11. Contract Research Organizations Case Studies
Figure 12. Diabetic Macular Edema Treatment Report Years Considered
Figure 13. Global Diabetic Macular Edema Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Diabetic Macular Edema Treatment Market Share by Regions: 2020 VS 2026
Figure 15. Global Diabetic Macular Edema Treatment Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Diabetic Macular Edema Treatment Market Share by Players in 2019
Figure 18. Global Top Diabetic Macular Edema Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Macular Edema Treatment as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Diabetic Macular Edema Treatment Revenue in 2019
Figure 20. North America Diabetic Macular Edema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Diabetic Macular Edema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Diabetic Macular Edema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Diabetic Macular Edema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Diabetic Macular Edema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Diabetic Macular Edema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Diabetic Macular Edema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
糖尿病性黄斑浮腫治療薬の世界市場（～2026年） Market Analysis and Insights: Global Diabetic Macular Edema Drug Market The global Diabetic Macular Edema Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Diabetic Macular Edema Drug Scope and Market Size Diabetic …- 黄斑浮腫治療薬の世界市場（～2026年） Macula is oval yellowish area surrounding the center of retina in the eye. Macular edema is the state when fluid and protein start accumulating under macula resulting swelling in the eye. Due to this swelling, central vision of eye get distorted. Macular edema is classified into two types namely cys…
- 嚢胞様黄斑浮腫の世界市場（～2026年） Cystoid macular edema (CME) also known as Irvine Gass Syndrome is a painless disorder affecting the central retina or macula. This condition is characterized by multiple cysts like areas of fluid in the macula causing retinal swelling or edema. CME is the retinal thickening of macula due to disrupti…
- 黄斑変性症（AMD）・糖尿病性網膜症（DR）治療薬の世界市場（～2026年） Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above. Diabetic retinopathy is an ophthalmic disorder, in which b…
- 若年性黄斑変性症（シュタルガルト病）治療の世界市場（～2026年） Macular degeneration is a group of eye disease commonly found among children and adults. There are various types of macular degeneration affecting the teens such as Cone-Rod Dystrophy, Best disease, Stargardt disease, Corneal Dystrophy, and Fuch’s Dystrophy. Asia Pacific is expected to be the fastes…